- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
April 4th, 2007
n health sector news, Australian bio-nanotech Psivida Ltd. surged 80 cents, or 39.2 percent, to $2.84 in the early session after signing an exclusive research and license agreement for its drug delivery technology with Pfizer Inc.
Under the agreement, which centers on ophthalmic, or eye-care products, Psivida will receive up to $155 million in development and sales-related milestone payments, and royalties on future products.
|Related News Press|
Nanometrics Announces Upcoming Investor Events November 18th, 2015
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
Electric fields remove nanoparticles from blood with ease November 24th, 2015
Researchers find new, inexpensive way to clean water from oil sands production November 24th, 2015
Breakthrough allows tracking of single molecules in 3-D with nanoscale accuracy:New method builds on Nobel Prize-winning technique, with exciting implications for understanding the inner workings of cells and neurons November 23rd, 2015